As of 2026-09-11, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (4.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.99 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -122.4%.
The range of the Relative Valuation is (4.40) - (4.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 18.8x | 17.4x |
| Forward P/E multiples | 15.4x - 16.8x | 15.8x |
| Fair Price | (4.40) - (4.74) | (4.69) |
| Upside | -121.0% - -122.6% | -122.4% |
| Date | P/E |
| 2026-09-09 | -73.26 |
| 2026-09-08 | -74.40 |
| 2026-09-04 | -73.58 |
| 2026-09-03 | -74.25 |
| 2026-09-02 | -76.20 |
| 2026-09-01 | -74.64 |
| 2026-08-31 | -73.80 |
| 2026-08-28 | -74.61 |
| 2026-08-27 | -73.69 |
| 2026-08-26 | -76.66 |
| 2026-08-25 | -75.67 |
| 2026-08-24 | -75.46 |
| 2026-08-21 | -77.01 |
| 2026-08-20 | -75.46 |
| 2026-08-19 | -75.17 |
| 2026-08-18 | -76.27 |
| 2026-08-17 | -75.92 |
| 2026-08-14 | -76.02 |
| 2026-08-13 | -74.86 |
| 2026-08-12 | -77.90 |
| 2026-08-11 | -75.07 |
| 2026-08-10 | -73.12 |
| 2026-08-07 | -75.74 |
| 2026-08-06 | -71.28 |
| 2026-08-05 | -67.85 |
| 2026-08-04 | -69.34 |
| 2026-08-03 | -73.32 |
| 2026-07-31 | -68.17 |
| 2026-07-30 | -63.89 |
| 2026-07-29 | -57.18 |
| 2026-07-28 | -53.57 |
| 2026-07-27 | -53.11 |
| 2026-07-24 | -52.86 |
| 2026-07-23 | -51.87 |
| 2026-07-22 | -53.07 |
| 2026-07-21 | -53.60 |
| 2026-07-20 | -53.25 |
| 2026-07-17 | -53.92 |
| 2026-07-16 | -55.94 |
| 2026-07-15 | -56.33 |
| 2026-07-14 | -54.88 |
| 2026-07-13 | -55.76 |
| 2026-07-10 | -55.16 |
| 2026-07-09 | -56.89 |
| 2026-07-08 | -57.78 |
| 2026-07-07 | -56.12 |
| 2026-07-06 | -56.68 |
| 2026-07-02 | -54.31 |
| 2026-07-01 | -53.68 |
| 2026-06-30 | -51.73 |